Omada Health, Inc.
OMDA
$17.10
-$0.08-0.47%
NASDAQ
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | 56.61% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 56.61% | ||||
| Cost of Revenue | 29.95% | ||||
| Gross Profit | 83.88% | ||||
| SG&A Expenses | 19.08% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 19.35% | ||||
| Operating Income | 53.34% | ||||
| Income Before Tax | 50.19% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 50.19% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 50.19% | ||||
| EBIT | 53.34% | ||||
| EBITDA | 58.13% | ||||
| EPS Basic | 54.71% | ||||
| Normalized Basic EPS | 54.71% | ||||
| EPS Diluted | 54.71% | ||||
| Normalized Diluted EPS | 54.71% | ||||
| Average Basic Shares Outstanding | 9.98% | ||||
| Average Diluted Shares Outstanding | 9.98% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||